GlassScriptPhysician profile
Michael Lepore
NPI 1780685172
$19,163.87
in general payments reported to CMS, 2019-2025
23 companies · $2,293 in 2025
The $2,293 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,813 · 2020: $810 · 2021: $1,331 · 2022: $1,826 · 2023: $2,770 · 2024: $2,321 · 2025: $2,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,865 · Long Term Medical Supply Or Device Loan: $2,400 · Travel and Lodging: $94.00 · Education: $24.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,865.23 |
| Long Term Medical Supply Or Device Loan | $2,400.00 |
| Travel and Lodging | $94.00 |
| Education | $24.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,855.13 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $4,234.59 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Angiodynamics, INC. | $2,484.40 | 2022-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Cook Medical LLC | $1,828.76 | 2019-2025 | Zilver Ptx, Zenith Spiral-Z |
| Penumbra, INC. | $1,534.72 | 2019-2025 | Indigo System, Penumbra System |
| Silk Road Medical, INC. | $708.53 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $520.89 | 2021-2024 | Endurant Iis |
| Philips North America LLC | $343.66 | 2022-2025 | (Az7) Lasers, Igt Devices Undivided, (Br5) Peripheral Ivus |
| Janssen Pharmaceuticals, INC | $342.66 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $302.24 | 2021-2025 | General - Catheters, Eluvia |
| Abbott Laboratories | $264.90 | 2022-2025 | Supera, Perclose Prostyle, Xact |
| Terumo Medical Corporation | $225.33 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $140.20 | 2020-2021 | |
| Cardiovascular Systems INC. | $91.97 | 2019-2020 | |
| Smith+Nephew, INC. | $64.35 | 2024-2025 | Renasys Touch, Stravix, Grafix Pl |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $61.82 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Inari Medical, INC. | $44.62 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biocompatibles, INC. | $29.26 | 2019 | |
| Tactile Systems Technology INC | $23.00 | 2025 | Nimbl, Flexitouch Plus |
| Cagent Vascular INC | $20.00 | 2025 | Serrantor |
| Lemaitre Vascular, INC. | $15.96 | 2019 | |
| Pfizer INC. | $14.08 | 2023 | |
| Kci USA, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lepore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.